V. Matveev

Pulmonary and Respiratory Medicine · European Urology · 2007–2017

A researcher in the Science corpus: 10 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom V. Matveev trusts

Their strongest outbound trust, strongest first, inferred from their citations.

  1. A. Billis (in Pulmonary and Respiratory Medicine)

Papers from V. Matveev's perspective

Ordered by how strongly the researchers V. Matveev trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Screening and prostate-cancer mortality in a randomized European study. (New England Journal of Medicine)
  2. Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. (Journal of Clinical Oncology)
  3. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. (New England Journal of Medicine)
  4. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer. (New England Journal of Medicine)
  5. Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. (Journal of Urology)
  6. Comparative effectiveness of minimally invasive vs open radical prostatectomy. (Journal of the American Medical Association (JAMA))
  7. Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a systematic review and cumulative analysis of comparative studies. (European Urology)
  8. International variation in prostate cancer incidence and mortality rates. (European Urology)
  9. Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer. (Journal of the National Cancer Institute)
  10. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. (European Urology)

Their papers